Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

NCT03891602 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT03891602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03891602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening
Lead sponsor
Hackensack Meridian Health
Phase
Observational
Overall status
Completed
Start date
March 22, 2019
Completion date
January 10, 2023
Enrollment
654 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, smoking, smoking, cigarette, smoking, tobacco